Overview

What they do
Monograph Capital is a life sciences venture firm. We find and fund groundbreaking life sciences companies to transform promising science into real, life-changing treatments for people across the world.
monograph.bio
What they look for
Monograph Capital partners with early-stage companies and entrepreneurs, combining differentiated sourcing, pharma relationships, deep medical expertise, and operating experience to support breakthrough healthcare innovations and improve patient outcomes.
monograph.bio
Stage
Seed, Series A, Series B+
monograph.bio
Sectors
Healthcare, AI, Legal and compliance
monograph.bio
Based
London, GB
monograph.bio

Sources

2026-08-30monograph.bioWe find and fund innovative life sciences companies, aiming to help translate promising…
2026-08-30monograph.bioThe Monograph Capital team is comprised of M.D.s and PhDs with decades of experience in…
2026-08-30monograph.bioThe Seed funding round was co-led by Monograph and LifeArc Ventures alongside BGF, and the…

Portfolio, cheque size and the rest

The 15 companies they have backed that we can see, the cheque they write, and whether they are deploying right now.

Start free, no cardFree accounts see every record.